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Aim: To investigate the left atrial dilatation in an undetermined etiological group according to Trial of Org 10172 in Acute Stroke
Treatment (TOAST) and to evaluate the relationship between left atrial dilatation and stroke volume and localization.
Materials and methods: Files of patients admitted to our hospital (2000–2010) with acute ischemic stroke diagnosis were investigated.
The size of their left atrium was registered using the data from transthoracic echocardiogram. Lesion size and localization were registered
using brain MRI. Stroke etiology was categorized according to TOAST classification. The relationship between left atrial dilatation and
stroke volume and localization in the undetermined group was investigated.
Results: It was detected that 47% patients had left atrial dilatation. A significant difference was observed in the occurrence of left atrium
dilatation for the undetermined group compared to the other groups and infarct volume was found to be larger in patients having left
atrial dilation (P < 0.038).
Conclusion: Left atrial dilatation is an important etiological factor in the undetermined-cause group and it also affects stroke volume.
Key words: Left atrium, stroke, echocardiography

1. Introduction
Cerebrovascular diseases constitute the most common
category of neurological diseases. Large vessel atherosclerosis,
arterial thrombus formation, cardioembolism, and
atherosclerosis in small vessels take place in ischemic stroke
etiology. For less than 5% of ischemic stroke cases, etiological
factors like hereditary diseases, congenital vessel diseases,
primary and secondary vasculitis of central nervous system,
cerebral amyloid angiopathy, mitochondrial diseases, and
blood diseases are detected.
Cardiac strokes constitute 15%–20% of all ischemic
strokes (1). Cardioembolic strokes have a higher repetition
and mortality rate considering the long-term results in
comparison to other stroke subcategories.
In various studies, the requirement to examine
especially the left appendix for spontaneous echo contrast
and thrombus has been stated (2). It was also noted that
transesophageal echocardiogram has an important role
in the detection of those (3). It has been found that the
left atrial dilation is more common in patients with atrial
fibrillation (AF) (4). The annual risk of stroke caused by AF
varies between 3% and 8% (5).
* Correspondence: ahukoctas@yahoo.com

Certain clinical features are suggestive of cardioembolic
infarction, including sudden onset to maximal deficit,
decreased level of consciousness at onset, Wernicke’s
aphasia or global aphasia without hemiparesis, a Valsalva
maneuver at the time of stroke onset, and cooccurrence of
cerebral and systemic emboli (6,7).
The goal of this study is to determine the frequency of
left atrial dilatation in stroke patients and to search for the
effect of atrial dilation on stroke volume and localization.
2. Materials and methods
Files of 2380 patients who were admitted to the Neurology
Department of Başkent University Hospital between 2000
and 2010 were investigated. Of those, 330 were included in
the study since their medical charts included the required
amount of medical data for the target study, brain images,
and echocardiography data.
Patient complaints, personal history and family
history, previous stroke history, risk factors, and
electrocardiography (ECG), echocardiography, and Holter
findings were taken into consideration while patient files
were being investigated.
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All neuroradiological analyses that were related with
diagnosis and etiology (brain computed tomography
(CT), brain magnetic resonance imaging (MRI), diffusion
MRI, brain MRI angiography, carotid MRI angiography),
blood tests (lipid profile, homocysteine levels), ECGs,
echocardiographies, carotid Doppler ultrasonographies,
and 24-h ECGs (Holter) in selected patients were evaluated.
Radiographies of patients with stroke diagnosis were
examined. Patients with brain MRI and diffusion MRI
were included in the study. Patients with only brain CT
results were excluded.
Patients with ischemic stroke were taken into the study
by examining brain MR images. Volumes of the biggest
lesions were measured by examining axial cross-sections
on the printed copies of diffusion MR images by using the
rectangular estimation of morphometric volume (largest
diameter × depth × section thickness (0.5 cm)) (8). Infarct
locations were classified as anterior cerebral artery (ACA),
middle cerebral artery (MCA), posterior cerebral artery
(PCA), thalamic, anterior choroidal, cerebellar, and brain
stem.
Using clinical data and radiological images, patients
were classified into 5 groups following the TOAST
classification system: large-artery atherosclerosis (LAAS),
cardioembolic infarct (CEI), lacunar infarct (LAC),
stroke of other determined origin (ODE), and stroke of
undetermined origin (UDE) (9). Patients having stenosis
in the carotid vertebral system according to carotid
Doppler and carotid MR angiography findings were
included in the atherosclerosis group. Patients with atrial
fibrillation according to Holter and ECG results were
included in the cardioembolic group. Patients having no
atrial fibrillation or atherosclerotic vascular disease were
included in the undetermined group. Patients showing
no stroke symptoms and having small infarcts (0.2 to 20
mm in diameter) were included in the lacunar group.
Patients having other stroke etiology like hematological
disease, congenital vessel disease, primary and secondary
vasculitis of the central nervous system, cerebral amyloid
angiopathy, and mitochondrial diseases were included in
the other determined origin group.
Echocardiography results of patients were analyzed
to determine whether left atrial expansion existed. Left
atrium diameter were assessed statistically. Left atrial
enlargement was classified as mild (left atrial diameter:
4.1–4.6 cm in men or 3.9–4.2 cm in women), moderate
(4.7–5.1 cm in men or 4.3–4.6 cm in women), or severe
(≥5.2 cm in men or 4.7 cm in women) in accordance
with the recommendations of the American Society of
Echocardiography (10). The cut-off threshold value was
found to be 4 cm and diameter values above that threshold
were considered to represent left atrium expansion.
The study was presented to the ethics board and the
board gave approval for the study.

958

SPSS 11.5 was used for statistical analysis. Continuous
variables were represented as mean ± standard deviation
and median; categorical variables were represented as
numbers and percentages. The Mann–Whitney U Test was
used to compare continuous variables and the Kruskal–
Wallis Test was used to compare categorical variables. The
chi-square test was used to define the differences between
groups. Statistical significance level was set to P < 0.05.
3. Results
In this study, 330 (167 male, 163 female) patients treated in
our department were evaluated. It was seen that the most
common risk factor was hypertension, with a rate of 74.5%
when the risk factors of patients were analyzed. The second
most common risk factor was diabetes mellitus, at 28.2%.
and the third was coronary arterial disease, at 25.5%.
When distribution of patients according to infarct
localization was investigated, it was seen that 7 people had
ACA (2.1%), 210 people had MCA (63.6%), 25 people had
PCA (7.6%), 9 people had thalamic (2.7%), 7 people had
anterior choroidal (2.1%), 20 people had cerebellar (6.1%),
31 people had brain stem (9.3%), and 21 people (6.3%) had
infarct in more than 1 area (Figure 1).
According to the investigation done by TOAST
classification, LAAS in 48 patients (14.5%), CEI in 83
patients (25.2%), and LAC in 49 patients (14.8%) were
noted. Cause could not be determined in 125 patients
(37.9%) and multiple causes were determined in 25
patients (7.6%) (Figure 2).
According to transthoracic echocardiogram (TTE)
findings, the cause of cardioembolic stroke was primarily
left ventricular dysfunction at a rate of 51.6% (patient
group whose ejection fraction was below 50%), while
14.5% of patients had AF, 2.1% of patients had thrombus,
and 1.2% of patients had valve replacement (Figure 3).
According to TTE findings on middle and undefined
risk factors, 79% of patients had left ventricular concentric
hypertrophy, 46.7% of patients had left atrial dilation, 43%
of patients had calcified aorta, 18.2% of patients had mitral
annular calcification, and 1.2% of patients had septal
hypertrophy (Figure 4).
In our study, it was seen that 154 patients had left atrial
dilation when the relationship between left atrial dilation
and infarct volume (which is defined as middle/undefined
risk factor) was analyzed. Infarct volume was found to be
larger on a statistically significant level for the patients
with left atrial dilation (P < 0.038) (Table 1).
When the frequency of left atrial dilatation in
the undetermined group was analyzed (Table 2), the
existence of left atrial dilatation in the cardioembolic and
undetermined groups was found to be significantly high (P
< 0.0001) compared to other groups according to TOAST
classification.
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Figure 1. Distribution of patients according to infarct localization. ACA: Anterior
cerebral artery, MCA: middle cerebral artery, PCA: posterior cerebral artery, Thal.:
thalamic , A. Chor.: anterior choroidal.
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Figure 2. Distribution of patients according to TOAST classification.

No difference was detected statistically for infarct
localization in patients who had left atrial dilatation (χ2 =
4.405, P = 0.732) (Table 3).
According to TOAST classification, left atrium dilation
was most frequent in the cardioembolic group, followed by
the undetermined cause group.
4. Discussion
Stroke is the world’s third most common cause of death
behind diseases of the heart and cancer (11). Ischemic
stroke, which has an increasing incidence rate with age,
is a complex multifactorial disorder that is affected by
environmental and genetic factors (12). Considering
the biological and socioeconomic damage of stroke, it is
essential to determine stroke risk factors in detail and take
precautions to decrease the prevalence and incidence of
stroke.
Twenty percent of ischemic strokes have cardiological
origins. Cardioembolic strokes usually have more severe

clinical status and a higher risk of recurrence in the
short term compared to other stroke groups (13,14).
Echocardiography serves as the cornerstone in evaluating
patients who may have had a cardioembolic stroke (15).
Although there are many studies on echocardiogram
findings and acute stroke diagnosis, they were all focused
on echocardiogram findings and cause of stroke (16,17).
Relationship between echocardiogram findings and infarct
localization and volume has been investigated for the first
time in this study. In addition, while there are many studies
on atrial septal defect (18,19) and patent foramen ovale
(20–22), which are echocardiogram findings, and strokes
with undetermined cause, the number of studies on the
relationship between medium uncertain risk factors and
acute strokes of undetermined cause is very small.
The reason for having a high number of patients in the
undetermined stroke group in our study is the inclusion
of patients without AF and LAAS to this group. In these
patients there are additional etiological risk factors.
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Figure 3. Cause of cardioembolic stroke according to TTE. AF: Atrial fibrillation.
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Figure 4. Distribution of patients with middle/undefined risk factors. LV: Left
ventricular, LA: left atrial.

It is thought that left atrial dilatation is related with
poor clinical course such as cardiac failure, AF, or stroke
development (23–25). The relationship of left atrial
dilatation and stroke has been supported by some studies,
although in some studies no relationship with stroke was
found.
Patients that were involved in the Atherosclerosis
Risk in Communities (ARIC) study were taken into the
Table 1. Infarct volumes according to left atrium diameter.
Infarct volume
Mean ± SD
[Median (min–max)]
With atrial dilatation
(left atrium diameter of >4 cm)

177.16 ± 29.36
[4.91 (0.02–278.4)]

Without left atrial dilatation
(left atrium diameter of <4 cm)

155.3 ± 29.41
[1.96 (0.03–158.4)]
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scope of study that was done by Nagarajarao et al. (26).
The study was done among 1886 patients. At the end of
the study, it was found that left atrial dilatation increased
stroke and death risk, besides many other cardiovascular
risks. Meanwhile, 472 people were included in the study
done by Kim et al. Seventy-five people had experience a
stroke for the first time and 397 healthy people were taken
as he control group. At the end of the study, a significant
relationship between stroke frequency and left atrial
dilatation existence was found. It was emphasized that left
atrial dilatation existence should be underlined in patients
with sinus rhythm (27).
A study done by Barnes et al. involved 1554 patients
retrospectively. Patients did not have previously known
AF. As a result of this study, left atrium volume was found
to be an independent risk factor in patients not having AF
previously and having stroke for the first time. In addition,
it was reported as an independent risk factor for risk of
death (28).
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Table 2. Frequency of left atrial dilatation occurrence according to TOAST. LAAS: Large-artery
atherosclerosis, CEI: cardioembolic infarct, LAC: lacunar infarct, UDE: undetermined origin.
LAAS

CEI

LAC

UDE

Number of patients that do not have left atrial dilatation

36

17

35

82

% of total

10.9%

5.1%

10.6%

24.8%

% in TOAST group

75%

20.5%

71.4%

65.6%

Number of patients that have left atrial dilatation

12

66

14

43

% of total

3.6%

20%

4.2%

13%

% in TOAST group

25%

79.5%

28.6%

34.4%

Table 3. Infarct location in patients with and without left atrial dilatation.
ACA: Anterior cerebral artery, MCA: middle cerebral artery, PCA:
posterior cerebral artery.
Left atrial dilatation
Infarct location

ACA

Absent

Present

Number of
patients

%

Number of
patients

%

4

2.3%

3

2.0%

MCA

110

62.1%

100

65.4%

PCA

15

8.5%

10

6.5%

Thalamic

7

4.0%

2

1.3%

Choroidal

3

1.7%

4

2.6%

Cerebellar

11

6.2%

9

5.9%

Medullar

18

10.2%

13

8.5%

Other

9

5.1%

12

7.8%

Total

177

100.0%

153

100.0%

A study by Benjamin et al. included 1371 male patients
and 1728 female patients. Stroke was encountered in 64
males and 73 females at the end of 8 years of observation.
At the end of the study, it was stated that the diameter of
the left atrium had a correlation with stroke risk in males
and was also correlated with death risk in both sexes. The
mechanism of this increased risk could not be determined
precisely; it was assumed to be multifactorial (29).
In our study, different than these other studies, infarct
volume and location were examined in patients with
left atrial dilatation, and it was seen that infarct volume
was higher in patients that had left atrial dilatation. Left
atrial dilatation should be checked in infarcts without any
known cause and left atrial dilatation should be considered
as a cardioembolic risk factor.
When TOAST classification was followed, it was
seen that left atrial dilatation was most frequent in the

cardioembolic group. This was an expected situation
since left atrial dilatation was observed together with AF
in the cardioembolic group. However, left atrial dilatation
had the second highest frequency in the undetermined
cause group, after the cardioembolic group, which was a
surprising finding and implies that having only left atrial
dilatation in the undetermined cause group should be
evaluated as a risk factor.
Studies investigating the relationship between left atrial
dilatation and stroke can be performed on larger patient
groups and for longer time periods in the future; thus,
it might be possible to start protective treatment earlier.
It is important to know under which risk conditions the
treatment process should be started in order to decrease
the death and disability incidences caused by stroke.
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